Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study.
Lanternier F, Tubach F, Ravaud P, Salmon D, Dellamonica P, Bretagne S, Couret M, Bouvard B, Debandt M, Gueit I, Gendre JP, Leone J, Nicolas N, Che D, Mariette X, Lortholary O; Research Axed on Tolerance of Biotherapies Group.
Lanternier F, et al. Among authors: tubach f.
Chest. 2013 Sep;144(3):990-998. doi: 10.1378/chest.12-2820.
Chest. 2013.
PMID: 23744173
Clinical Trial.